These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16370941)

  • 1. Aerosolised antibiotics: a critical appraisal of their use.
    Hagerman JK; Hancock KE; Klepser ME
    Expert Opin Drug Deliv; 2006 Jan; 3(1):71-86. PubMed ID: 16370941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhaled antibiotic therapy in other respiratory diseases].
    Baranda F; Gómez A; Gómez B
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():24-9. PubMed ID: 21703476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled antimicrobial therapy.
    O'Riordan T; Faris M
    Respir Care Clin N Am; 1999 Dec; 5(4):617-31. PubMed ID: 10565884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia.
    Wood GC; Swanson JM
    Drugs; 2007; 67(6):903-14. PubMed ID: 17428107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary deposition of colistin aerosols in cystic fibrosis. Comparison of an ultrasonic nebulizer and a pneumatic nebulizer].
    Gagnadoux F; Diot P; Marchand S; Thompson R; Dieckman K; Lemarié E; Varaigne F; Maurage C; Baulieu JL; Rolland JC
    Rev Mal Respir; 1996; 13(1):55-60. PubMed ID: 8650418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled antibiotics to treat lung infection.
    Cipolla D; Chan HK
    Pharm Pat Anal; 2013 Sep; 2(5):647-63. PubMed ID: 24237172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B.
    Solé A
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S161-5. PubMed ID: 19013342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerosolized antimicrobials: another look.
    Itokazu GS; Weinstein RA
    Crit Care Med; 1998 Jan; 26(1):5-6. PubMed ID: 9428531
    [No Abstract]   [Full Text] [Related]  

  • 9. Disposable versus reusable jet nebulizers for cystic fibrosis treatment with tobramycin.
    Vecellio L; Abdelrahim ME; Montharu J; Galle J; Diot P; Dubus JC
    J Cyst Fibros; 2011 Mar; 10(2):86-92. PubMed ID: 21075063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled Liposomal Antimicrobial Delivery in Lung Infections.
    Bassetti M; Vena A; Russo A; Peghin M
    Drugs; 2020 Sep; 80(13):1309-1318. PubMed ID: 32691293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives.
    Sugianto TD; Chan HK
    Expert Opin Drug Deliv; 2016; 13(1):7-22. PubMed ID: 26289675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivering drugs to the lungs: The history of repurposing in the treatment of respiratory diseases.
    Newman SP
    Adv Drug Deliv Rev; 2018 Aug; 133():5-18. PubMed ID: 29653129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choosing a nebulizer for cystic fibrosis applications.
    Geller DE
    Curr Opin Pulm Med; 1997 Nov; 3(6):414-9. PubMed ID: 9391760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
    Cheer SM; Waugh J; Noble S
    Drugs; 2003; 63(22):2501-20. PubMed ID: 14609360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis.
    Pilcer G; De Bueger V; Traina K; Traore H; Sebti T; Vanderbist F; Amighi K
    Int J Pharm; 2013 Jul; 451(1-2):112-20. PubMed ID: 23643509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivering antibiotics to the lungs of patients with ventilator-associated pneumonia: an update.
    Luyt CE; Bréchot N; Combes A; Trouillet JL; Chastre J
    Expert Rev Anti Infect Ther; 2013 May; 11(5):511-21. PubMed ID: 23627857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patients.
    Westerman EM; Heijerman HG; Frijlink HW
    Expert Opin Drug Deliv; 2007 Mar; 4(2):91-4. PubMed ID: 17335406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to optimizing antimicrobial therapy in patients with cystic fibrosis.
    Beringer PM
    Curr Opin Pulm Med; 1999 Nov; 5(6):371-7. PubMed ID: 10570739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TOBI: reducing the impact of pseudomonal infection.
    Govan J
    Hosp Med; 2002 Jul; 63(7):421-5. PubMed ID: 12187603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into cystic fibrosis microbiology from the European tobramycin trial in cystic fibrosis.
    Govan JR
    J Cyst Fibros; 2002 Dec; 1(Suppl 2):203-8. PubMed ID: 15463836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.